Total Funding
68
59
Total FundingSeries B raised
Growth Score 68 in past quarter
-9 pts
Heat Score 59 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
31663
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.
- Past Role: OncoImmune, Chief Operating Officer
- Shiniu Wei: Chief Financial OfficerPast Role: Fosun International, Executive Director, Secondary Market Investment Department
About the Company
OncoC4 is a clinical-stage biotechnology company that is actively engaged in the discovery and development of novel biologics for the potential treatment of cancer and neurodegenerative disease.
